Understanding Persistent Signs and Symptoms Attributed to Post-Treatment Lyme Disease (R01 Clinical Trial Not Allowed)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website    Save this grant

Next deadline: Oct 8, 2022 (Letter of inquiry)

Later deadlines: Nov 8, 2022 (Full proposal)

Grant amount: Up to US $400,000

Fields of work: Lyme Disease

Applicant type: Government Entity, Indigenous Group, Nonprofit, For-Profit Business

Funding uses: Research

Location of project: United States

Location of residency: United States


The purpose of this Funding Opportunity Announcement (FOA) is to support research on the underlying cause(s) of signs and symptoms that may persist following a Lyme disease diagnosis and antibiotic treatment.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Other Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

This page was last reviewed July 21, 2022 and last updated July 21, 2022